[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

China Interferon Market Survey and Trend Research 2018

November 2017 | 88 pages | ID: C2E78150FDBEN
99Strategy

US$ 2,600.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Interferon is mainly used for the treatment of hepatitis B, hepatitis C, multiple sclerosis, condyloma acuminatum and other diseases.

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain
  • Raw Materials
  • Cost
  • Technology
  • Consumer Preference
Industry Overall:
  • History
  • Development & Trend
  • Market Competition
  • Trade Overview
  • Policy
Region (North China, Northeast China, Southern China, East China, Central China, Southwest China, Northwest China):
  • Regional Market
  • Production Development
  • Sales
  • Regional Trade
  • Regional Forecast
Company (Roche, MSD, Anke Biotechnology, Tri-Prime Gene, Kawin Technology, Amoytop Biotech, Shenzhen Kexing Biotech, Sinobioway Biomedicine, 3SBio, Harbin Pharmaceutical Group Bioengineering, Changchun Institute of Biological Products, Zhejiang Hansheng Pharmaceutical of Beisheng Pharma, Hainan Xinmingda Biopharmaceutical, Beijing Yuance Pharmaceutical, Heilongjiang Qingfengyuan Biological Engineering Technology, Liaoning Satellite Institute of Biological Products, Shanghai Chemo Wanbang Biopharma, Changchun Heber Biological Technology, Shanghai Huaxin High Biotechnology etc.):
  • Company Profile
  • Product & Service
  • Business Operation Data
  • Market Share
Investment Analysis:
  • Market Features
  • Investment Opportunity
  • Investment Calculation
PART 1 INDUSTRY OVERVIEW

1.1 Interferon Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 INTERFERON MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast
4 Key Companies List
4.1 Roche (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 MSD (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Anke Biotechnology (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Tri-Prime Gene (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Kawin Technology (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Amoytop Biotech (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Shenzhen Kexing Biotech (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Sinobioway Biomedicine (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 3SBio (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Harbin Pharmaceutical Group Bioengineering (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Changchun Institute of Biological Products (Company Overview, Sales Data etc.)
4.12 Zhejiang Hansheng Pharmaceutical of Beisheng Pharma (Company Overview, Sales Data etc.)
4.13 Hainan Xinmingda Biopharmaceutical (Company Overview, Sales Data etc.)
4.14 Beijing Yuance Pharmaceutical (Company Overview, Sales Data etc.)
4.15 Heilongjiang Qingfengyuan Biological Engineering Technology (Company Overview, Sales Data etc.)
4.16 Liaoning Satellite Institute of Biological Products (Company Overview, Sales Data etc.)
4.17 Shanghai Chemo Wanbang Biopharma (Company Overview, Sales Data etc.)
4.18 Changchun Heber Biological Technology (Company Overview, Sales Data etc.)
4.19 Shanghai Huaxin High Biotechnology (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

LIST OF TABLES

Table China Interferon Market 2012-2017, by Type, in USD Million
Table China Interferon Market Forecast 2018-2023, by Type, in USD Million
Table Roche Overview List
Table Interferon Business Operation of Roche (Sales Revenue, Cost, Gross Margin)
Table MSD Overview List
Table Interferon Business Operation of MSD (Sales Revenue, Cost, Gross Margin)
Table Anke Biotechnology Overview List
Table Interferon Business Operation of Anke Biotechnology (Sales Revenue, Cost, Gross Margin)
Table Tri-Prime Gene Overview List
Table Interferon Business Operation of Tri-Prime Gene (Sales Revenue, Cost, Gross Margin)
Table Kawin Technology Overview List
Table Interferon Business Operation of Kawin Technology (Sales Revenue, Cost, Gross Margin)
Table Amoytop Biotech Overview List
Table Interferon Business Operation of Amoytop Biotech (Sales Revenue, Cost, Gross Margin)
Table Shenzhen Kexing Biotech Overview List
Table Interferon Business Operation of Shenzhen Kexing Biotech (Sales Revenue, Cost, Gross Margin)
Table Sinobioway Biomedicine Overview List
Table Interferon Business Operation of Sinobioway Biomedicine (Sales Revenue, Cost, Gross Margin)
Table 3SBio Overview List
Table Interferon Business Operation of 3SBio (Sales Revenue, Cost, Gross Margin)
Table Harbin Pharmaceutical Group Bioengineering Overview List
Table Interferon Business Operation of Harbin Pharmaceutical Group Bioengineering (Sales Revenue, Cost, Gross Margin)
Table Changchun Institute of Biological Products Overview List
Table Interferon Business Operation of Changchun Institute of Biological Products (Sales Revenue, Cost, Gross Margin)
Table Zhejiang Hansheng Pharmaceutical of Beisheng Pharma Overview List
Table Interferon Business Operation of Zhejiang Hansheng Pharmaceutical of Beisheng Pharma (Sales Revenue, Cost, Gross Margin)
Table Hainan Xinmingda Biopharmaceutical Overview List
Table Interferon Business Operation of Hainan Xinmingda Biopharmaceutical (Sales Revenue, Cost, Gross Margin)
Table Beijing Yuance Pharmaceutical Overview List
Table Interferon Business Operation of Beijing Yuance Pharmaceutical (Sales Revenue, Cost, Gross Margin)
Table Heilongjiang Qingfengyuan Biological Engineering Technology Overview List
Table Interferon Business Operation of Heilongjiang Qingfengyuan Biological Engineering Technology (Sales Revenue, Cost, Gross Margin)
Table Liaoning Satellite Institute of Biological Products Overview List
Table Interferon Business Operation of Liaoning Satellite Institute of Biological Products (Sales Revenue, Cost, Gross Margin)
Table Shanghai Chemo Wanbang Biopharma Overview List
Table Interferon Business Operation of Shanghai Chemo Wanbang Biopharma (Sales Revenue, Cost, Gross Margin)
Table Changchun Heber Biological Technology Overview List
Table Interferon Business Operation of Changchun Heber Biological Technology (Sales Revenue, Cost, Gross Margin)
Table Shanghai Huaxin High Biotechnology Overview List
Table Interferon Business Operation of Shanghai Huaxin High Biotechnology (Sales Revenue, Cost, Gross Margin)
Table China Interferon Sales Revenue 2012-2017, by Companies, in USD Million
Table China Interferon Sales Revenue Share, by Companies, in USD Million
Table Interferon Demand 2012-2017, by Application, in USD Million
Table Interferon Demand Forecast 2018-2023, by Application, in USD Million
Table China Interferon Market 2012-2017, by Region, in USD Million
Table Interferon Market Forecast 2018-2023, by Region, in USD Million

LIST OF FIGURES

Figure Interferon Industry Chain Structure
Figure China Interferon Market Growth 2012-2017, by Type, in USD Million
Figure China Interferon Sales Revenue Share, by Companies in 2017, in USD Million
Figure Production Development by Region
Figure Sales List by Region


More Publications